Literature DB >> 561860

Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells.

J L Schulman, P Palese.   

Abstract

The genetic basis for the distinctive capacity of influenza A/WSN/33 (H0N1) virus (WSN virus) to produce plaques on bovine kidney (MDBK) cells was found to be related to virus neuraminidase. Recombinant viruses that derived only the neuraminidase of WSN virus were capable of producing plaques, whereas recombinant viruses identical to WSN except for neuraminidase did not produce plaques. With viruses that do not contain WSN neuraminidase, infectivity of virus yields from MDBK cells was increased approximately 1,000-fold after in vitro treatment with trypsin. In contrast, no significant increase in infectivity was observed after trypsin treatment of viruses containing WSN neuraminidase. In addition, polyacrylamide gel analysis of proteins of WSN virus obtained after infection of MDBK cells demonstrated that hemagglutinin was present in the cleaved form (HA1 + HA2), whereas only uncleaved hemagglutinin was obtained with a recombinant virus that derived all of its genes from WSN virus except its neuraminidase. These data are in accord with the hypothesis that neuraminidase may facilitate production of infectious particles by removing sialic acid residues and exposing appropriate cleavage sites on hemagglutinin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 561860      PMCID: PMC515920     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids.

Authors:  D AMINOFF
Journal:  Biochem J       Date:  1961-11       Impact factor: 3.857

2.  Selection and identification of influenza virus recombinants of defined genetic composition.

Authors:  J L Schulman; P Palese
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

3.  Isolation and characterization of influenza virus recombinants with high and low neuraminidase activity. Use of 2-(3'-methoxyphenyl)-n-acetylneuraminic acid to identify cloned populations.

Authors:  P Palese; J Schulman
Journal:  Virology       Date:  1974-01       Impact factor: 3.616

4.  Separation of single-stranded ribonucleic acids by acrylamide-agarose-urea gel electrophoresis.

Authors:  R W Floyd; M P Stone; W K Joklik
Journal:  Anal Biochem       Date:  1974-06       Impact factor: 3.365

5.  P1 and P3 proteins of influenza virus are required for complementary RNA synthesis.

Authors:  P Palese; M B Ritchey; J L Schulman
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

6.  Difference in protein patterns of influenza A viruses.

Authors:  M B Ritchey; P Palese; J L Schulman
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

7.  Mapping of the influenza virus genome. II. Identification of the P1, P2, and P3 genes.

Authors:  P Palese; M B Ritchey; J L Schulman
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

8.  Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.

Authors:  P Palese; R W Compans
Journal:  J Gen Virol       Date:  1976-10       Impact factor: 3.891

9.  Mapping of the influenza virus genome. III. Identification of genes coding for nucleoprotein, membrane protein, and nonstructural protein.

Authors:  M B Ritchey; P Palese; J L Schulman
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

10.  Identification of the defective genes in three mutant groups of influenza virus.

Authors:  M B Ritchey; P Palese
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

View more
  62 in total

1.  Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens.

Authors:  Diane J Hulse; Robert G Webster; Rupert J Russell; Daniel R Perez
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

Review 3.  Influenza virus hemagglutinin cleavage into HA1, HA2: no laughing matter.

Authors:  J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

4.  Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

Authors:  T Muster; R Guinea; A Trkola; M Purtscher; A Klima; F Steindl; P Palese; H Katinger
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.

Authors:  T Muster; B Ferko; A Klima; M Purtscher; A Trkola; P Schulz; A Grassauer; O G Engelhardt; A García-Sástre; P Palese
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase.

Authors:  S Shibata; F Yamamoto-Goshima; K Maeno; T Hanaichi; Y Fujita; K Nakajima; M Imai; T Komatsu; S Sugiura
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Structural features influencing hemagglutinin cleavability in a human influenza A virus.

Authors:  Y Kawaoka
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Glycosylation and surface expression of the influenza virus neuraminidase requires the N-terminal hydrophobic region.

Authors:  L Markoff; B C Lin; M M Sveda; C J Lai
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

9.  A novel mechanism for the acquisition of virulence by a human influenza A virus.

Authors:  H Goto; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  A plasmid-based reverse genetics system for influenza A virus.

Authors:  S Pleschka; R Jaskunas; O G Engelhardt; T Zürcher; P Palese; A García-Sastre
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.